Oriental Carbon & Chemicals Ltd
Incorporated in 1978, Oriental Carbon & Chemicals Ltd sells Chemicals (Insoluble Sulphur, Sulphuric acid) and has other Investments[1]
- Market Cap ₹ 229 Cr.
- Current Price ₹ 229
- High / Low ₹ 415 / 147
- Stock P/E 34.6
- Book Value ₹ 252
- Dividend Yield 6.10 %
- ROCE 9.06 %
- ROE 7.08 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.91 times its book value
- Stock is providing a good dividend yield of 6.10%.
- Company has been maintaining a healthy dividend payout of 33.2%
Cons
- The company has delivered a poor sales growth of 0.70% over past five years.
- Company has a low return on equity of 7.26% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Finance Industry: Finance & Investments
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
225 | 262 | 283 | 271 | 297 | 324 | 383 | 340 | 341 | 386 | 465 | 397 | 98 | |
168 | 193 | 210 | 189 | 208 | 224 | 261 | 241 | 219 | 308 | 368 | 304 | 78 | |
Operating Profit | 58 | 69 | 72 | 82 | 89 | 100 | 123 | 99 | 122 | 78 | 96 | 93 | 20 |
OPM % | 26% | 26% | 26% | 30% | 30% | 31% | 32% | 29% | 36% | 20% | 21% | 23% | 20% |
5 | 3 | 12 | 5 | 6 | 4 | 7 | 10 | 2 | 8 | 2 | 4 | -355 | |
Interest | 13 | 11 | 8 | 6 | 5 | 8 | 8 | 9 | 6 | 8 | 13 | 11 | 3 |
Depreciation | 10 | 10 | 13 | 16 | 15 | 16 | 19 | 20 | 21 | 23 | 28 | 29 | 8 |
Profit before tax | 40 | 50 | 63 | 65 | 75 | 80 | 103 | 79 | 97 | 55 | 57 | 58 | -346 |
Tax % | 32% | 19% | 18% | 18% | 27% | 29% | 28% | 10% | 22% | 27% | 24% | 25% | |
27 | 40 | 51 | 53 | 54 | 57 | 74 | 72 | 75 | 40 | 44 | 43 | -349 | |
EPS in Rs | 26.58 | 39.26 | 49.83 | 51.45 | 52.59 | 55.10 | 73.74 | 71.51 | 75.00 | 39.95 | 43.71 | 42.95 | -348.79 |
Dividend Payout % | 19% | 18% | 17% | 17% | 19% | 18% | 16% | 14% | 19% | 35% | 32% | 33% |
Compounded Sales Growth | |
---|---|
10 Years: | 4% |
5 Years: | 1% |
3 Years: | 5% |
TTM: | -54% |
Compounded Profit Growth | |
---|---|
10 Years: | 1% |
5 Years: | -10% |
3 Years: | -17% |
TTM: | -73% |
Stock Price CAGR | |
---|---|
10 Years: | 9% |
5 Years: | -1% |
3 Years: | -2% |
1 Year: | 18% |
Return on Equity | |
---|---|
10 Years: | 13% |
5 Years: | 10% |
3 Years: | 7% |
Last Year: | 7% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Reserves | 162 | 194 | 234 | 276 | 333 | 378 | 404 | 458 | 523 | 547 | 584 | 616 | 242 |
118 | 104 | 91 | 73 | 103 | 117 | 125 | 154 | 185 | 188 | 165 | 138 | -0 | |
44 | 49 | 56 | 58 | 62 | 68 | 73 | 57 | 74 | 86 | 78 | 78 | 13 | |
Total Liabilities | 334 | 356 | 391 | 417 | 507 | 573 | 612 | 679 | 791 | 831 | 837 | 842 | 265 |
188 | 193 | 188 | 183 | 306 | 308 | 344 | 338 | 327 | 437 | 462 | 449 | 52 | |
CWIP | 3 | 2 | 4 | 40 | 3 | 40 | 3 | 25 | 113 | 41 | 1 | 1 | -0 |
Investments | 20 | 26 | 41 | 30 | 53 | 76 | 108 | 147 | 199 | 187 | 217 | 238 | 199 |
124 | 135 | 158 | 165 | 146 | 148 | 156 | 168 | 152 | 166 | 158 | 154 | 14 | |
Total Assets | 334 | 356 | 391 | 417 | 507 | 573 | 612 | 679 | 791 | 831 | 837 | 842 | 265 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
47 | 52 | 70 | 68 | 77 | 87 | 89 | 108 | 85 | 52 | 91 | 94 | |
-27 | -23 | -31 | -42 | -84 | -72 | -45 | -83 | -123 | -32 | -38 | -42 | |
-20 | -32 | -32 | -35 | 5 | -7 | -51 | -3 | 17 | -21 | -52 | -53 | |
Net Cash Flow | 0 | -3 | 7 | -9 | -2 | 8 | -8 | 22 | -22 | -1 | 0 | -0 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 64 | 66 | 67 | 65 | 94 | 85 | 80 | 72 | 80 | 76 | 59 | 68 |
Inventory Days | 199 | 204 | 160 | 204 | 168 | 185 | 164 | 138 | 185 | 160 | 122 | 154 |
Days Payable | 68 | 73 | 66 | 54 | 95 | 90 | 63 | 58 | 88 | 67 | 38 | 57 |
Cash Conversion Cycle | 195 | 197 | 160 | 215 | 167 | 180 | 181 | 152 | 177 | 169 | 143 | 165 |
Working Capital Days | 67 | 59 | 56 | 65 | 82 | 73 | 75 | 73 | 92 | 93 | 82 | 98 |
ROCE % | 19% | 21% | 22% | 21% | 20% | 18% | 22% | 15% | 15% | 8% | 9% | 9% |
Documents
Announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 14 Nov
- Newspaper Publication Of Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024 13 Nov
-
Board Meeting Outcome for Outcome Of Board Meeting
12 Nov - Board approved unaudited financial results for Q2 FY 2024.
-
Results
12 Nov - Approved unaudited financial results for Q2 FY 2024.
-
Board Meeting Intimation for Intimation Of Board Meeting And Closure Of Trading Window
6 Nov - Board meeting scheduled for financial results approval.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023TranscriptPPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT REC
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jun 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Nov 2020TranscriptNotesPPT
-
Aug 2020TranscriptNotesPPT
-
Jun 2020TranscriptNotesPPT
-
Jan 2020TranscriptNotesPPT
-
Oct 2019TranscriptNotesPPT
-
Jul 2019TranscriptNotesPPT
-
May 2019TranscriptNotesPPT
-
Feb 2019TranscriptNotesPPT
-
Nov 2018TranscriptNotesPPT
-
Jul 2018TranscriptNotesPPT
-
May 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Nov 2017TranscriptNotesPPT
-
Jul 2017TranscriptNotesPPT
-
May 2017TranscriptNotesPPT
-
May 2017TranscriptNotesPPT
-
Feb 2017TranscriptNotesPPT
-
Nov 2016TranscriptNotesPPT
-
Jul 2016TranscriptNotesPPT
-
Dec 2015TranscriptNotesPPT
Business Overview:[1][2]
OCCL belongs to the Duncan JP Goenka Group of Companies. It is an ISO40001 and ISO45001 certified manufacturer of customised and value added grades of Insoluble Sulphur